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ABBREVIATIONS
FAQ Gillette Functional Assessment
Questionnaire walking scale
FMS Functional Mobility Scale
GRS Global rating scale
MIC Minimal important change
ROC Receiver operating
characteristic
AIM To examine the responsiveness and minimal important change (MIC) of two gait
performance measures, the Functional Mobility Scale (FMS) and the Gillette Functional
Assessment Questionnaire walking scale (FAQ), in a paediatric inpatient setting.
METHOD Sixty-four children and adolescents with a motor disorder, including cerebral palsy,
traumatic brain injury, or stroke (25 females, 39 males; mean age [SD] 12y 6mo [3y 2mo],
range 6–18y 6mo), were recruited. Physiotherapists scored the FMS and FAQ at the start and
end of active gait rehabilitation. Change scores were compared with changes in gait capacity
tests, the walking item of the Functional Independence Measure for Children, and a global
rating scale (GRS) on the physiotherapists’ perceived change of the child’s functional
mobility. The GRS was also used to define the MIC.
RESULTS Change scores of the FMS and FAQ correlated between 0.35 and 0.49 with those of
the capacity tests, 0.54 to 0.76 with the Functional Independence Measure for Children
walking item change scores, and 0.57 to 0.76 with the GRS. The MIC values for the FMS and
FAQ were 0.5 and 1.5 respectively.
INTERPRETATION FMS and FAQ can illustrate change in inpatient gait performance of
children and adolescents with motor disorders. An improvement of one level in the FMS and
two levels in the FAQ is considered as a clinically meaningful change.
Clinicians and researchers rely on various outcome instru-
ments when they evaluate the effects of interventions that
aim at improving walking abilities in children with motor
disorders. With regard to the International Classification of
Functioning, Disability and Health for Children and Youth,
most of these instruments can be linked to the body function
domain or the capacity level of the activity domain.1,2
Capacity describes what a child can do in a standardized
controlled environment.3 Although walking capacity has an
impact on walking performance (i.e. how a child actually
moves in their environment in daily life), environmental and
personal factors seem to play an even more important role
and are valuable to integrate in constructs measuring walk-
ing ability.4 Within this perspective, walking performance is
defined as how children actually move around in their cur-
rent environment in everyday life.3
The Functional Mobility Scale (FMS) and the Gillette
Functional Assessment Questionnaire walking scale (FAQ)
are examples of the few tools that assess walking ability on
a performance level. The FMS describes the level of a
child’s functional mobility in everyday life over 5m, 50m,
and 500m, representing the home, school, and community
settings respectively.5 For each distance, an ordinal rating
from 1 to 6 is assigned depending on the amount of assis-
tance required for the child’s mobility. It is usually admin-
istered by a clinician in a semi-structured interview using
child-report or parent-report.5
The FAQ assesses the level of a child’s functional mobil-
ity on an ordinal scale by describing various levels of
mobility differing in environment, terrains, or obstacles.6
The scale ranges from 1 (the child cannot take any steps at
all) to 10 (the child walks, runs, and climbs on level and
uneven terrain without difficulty).6 It is a parent-report or
self-report measure to identify the child’s usual level of
function. Both the FMS and the FAQ are easy to use and
require no specific assessor training.7
To accurately measure and interpret a child’s perfor-
mance in clinical practice and research, assessments should
be sufficiently valid, reliable, and responsive. The COnsen-
sus-based Standards for the selection of health Measure-
ment INstruments group defined responsiveness as ‘the
ability of an instrument to detect change over time in the
construct to be measured’.8 Another relevant aspect is the
degree to which one can assign qualitative meaning to
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scores or change scores: in other words, the interpretability
of instruments.9 Minimal important change (MIC) is one
aspect of interpretability and is defined as ‘the smallest
change in score in the construct to be measured which
patients perceive as important’.8 For this, change scores
are related to a clinically meaningful reference (i.e. an
anchor-based approach) from a patient’s or clinician’s per-
spective. It is important that the anchor reflects the con-
struct that the target instrument aims to measure.9
The FMS correlated moderately to very strongly
(rs=0.58–0.89) with other gait measures in inpatient and
outpatient settings.5,10 Interrater agreement was substantial
to almost perfect in ambulatory children with motor disor-
ders.5,11,12 Furthermore, FMS scores obtained by parent
interview and direct observation agreed substantially,13 and
it seems to be responsive in an outpatient setting.5,6,11–14
The FAQ showed almost perfect intrarater and inter-
rater reliability as well as content and concurrent validity
compared with other measures of gait function in children
with various motor disorders.6 It has been used as an out-
come measure after various interventions.15,16 However, we
are unaware of studies focusing on the evaluation of the
responsiveness of the FAQ in a psychometric study design
in outpatients or inpatients.
Thus, our aim was to investigate responsiveness of the
FMS and FAQ in children and adolescents with motor dis-
orders in an inpatient neurorehabilitation setting by examin-
ing the correlations between changes over time in FMS and
FAQ scores with changes over time in standard functional
and capacity measures. We formulated the following four
hypotheses a priori, as follows. (1) Correlations between the
change scores of the FMS and FAQ and the change scores of
the comparator tests are positive and moderate to strong,
with Spearman’s correlation coefficients (rs) at least 0.4. (2)
Correlations between a global rating scale (GRS) quantify-
ing the therapists’ perceived change of the children’s func-
tional mobility in everyday life and the change scores of the
FMS and FAQ are stronger than the correlations between
the GRS and the change scores of the capacity measures. (3)
The values of the area under the receiver operating charac-
teristic (ROC) curves between the dichotomized GRS (no
change versus change [improvement]) and the FMS and
FAQ are at least 0.7. This threshold would indicate that the
measures could discriminate between children whose walk-
ing performance remained unchanged versus those who
changed (improved). (4) The change scores of the FMS and
FAQ in children who had received surgery are larger than in
non-operated children.
Further, we determined the MIC of the FMS and FAQ
by relating the change scores of the two measures to the
treating physiotherapists’ perceived change of the chil-
dren’s functional mobility.
METHOD
Study design and setting
This prospective longitudinal psychometric study used a
construct and criterion approach to evaluate responsiveness
and an anchor-based approach to assess the MIC of two
gait performance measures. Measurements were performed
at the Rehabilitation Center Affoltern am Albis of the
Children’s University Hospital Zurich, Switzerland. The
centre provides inpatient and outpatient treatment for chil-
dren and adolescents with predominantly congenital and
acquired neurological disorders. The most frequent reasons
for admission to the centre are postsurgical treatment and
improving independence in everyday life activities. The
study was approved by the Ethics Committee Zurich and
registered on ClinicalTrials.gov (NCT02237222).
Participants
Children and adolescents were eligible for the study if they
(1) were between 6 years and 18 years 11 months of age;
(2) had an acquired or congenital motor diagnosis, such as
stroke, traumatic brain injury, or cerebral palsy; (3) were
inpatients at the rehabilitation centre; and (4) their rehabil-
itation programme contained therapy sessions in which
they actively trained their gait function. Therapists
reported children who met these inclusion criteria. These
children and their parents subsequently received oral and
written study information by a research assistant and were
consecutively recruited between April 2014 and January
2016, provided that at least one parent understood Ger-
man well. Signed informed consent and assent by the legal
guardian and the child was given. Adhering to the criteria
provided by the COnsensus-based Standards for the selec-
tion of health Measurement INstruments (COSMIN)
guidelines, we aimed for a sample size of at least 50.17 In
total, 64 children and adolescents (25 females, 39 males;
mean age [SD] 12y 6mo [3y 2mo], range 6–18y 6mo),
were recruited.
Measures
For the FMS, we substituted the home (5m), school (50m),
and community (500m) settings11 into mobility within the
patient room, within the rehabilitation centre (between
ward, therapies, and inpatient school), and outside the
rehabilitation centre.
For the FAQ, we considered the children’s functional
mobility within the rehabilitation centre (levels 1–5) or
outside the rehabilitation centre (levels 6–10).6
The 6-Minute Walking Test investigates functional
capacity.18 Limited to moderate evidence exists for its con-
vergent validity with various body function parameters in
children with chronic conditions. Its test–retest reliability
in children with cerebral palsy is almost perfect,2,19,20 while
evidence for its responsiveness is limited and only available
for children with Duchenne muscular dystrophy.20
What this paper adds
• The Functional Mobility Scale (FMS) can detect change in children’s
inpatient gait performance.
• The Gillette Functional Assessment Questionnaire walking scale (FAQ) can
also detect change in children’s inpatient gait performance.
• A one-level improvement in the FMS is clinically relevant.
• A two-level improvement in the FAQ is clinically relevant.
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The 10-Metre Walking Test evaluates self-selected or
maximal gait speed over a short distance.21 Relative test–
retest reliability of the 10-Metre Walking Test is high in
children with neurological gait disorders.2,19
The Gross Motor Function Measure-88 is a standard-
ized tool for measuring gross motor function in children
with motor disabilities.22 The 24 ordinal-scale items of the
dimension E assess walking, running, and jumping abilities.
The psychometric properties of the total Gross Motor
Function Measure-88 are well explored, especially in chil-
dren with cerebral palsy.23 Evidence for the psychometric
properties of the single dimensions is mostly unknown.
Timed walking tests and the Gross Motor Function Mea-
sure Dimension E were mainly performed in children for
whom these tests were clinically indicated as part of their
inpatient rehabilitation programme.
The Functional Independence Measure for Children
assesses a child’s level of independence during various
activities of daily living on the performance level (Uniform
Data System for Medical Rehabilitation, Buffalo, NY,
USA). The items are scored on a 7-point ordinal scale.
Intraclass correlation coefficients of the locomotion sub-
scale are 0.94 to 0.97 for intrarater and 0.73 to 0.85 for
interrater reliability, and correlations with mobility
domains of other functional measures are strong.24,25 We
used only the walking item of the locomotion subscale.
A 5-point GRS (much worse, somewhat worse,
unchanged, somewhat better, much better), specifically
designed for this study, was used as an anchor, quantifying
the physiotherapists’ perceived change of the children’s
functional mobility by asking, ‘compared to the beginning
of active gait rehabilitation, how has the child’s functional
mobility in everyday life changed in your opinion?’.
Study procedure
We used the German versions of both questionnaires,
which had been approved by the authors of the original
English versions. Details about the translation procedure
and results on their reliability and validity are reported
elsewhere.10,12
Data on patients’ age, sex, diagnosis, and length of reha-
bilitation stay were collected from their electronic medical
records. Measurements took place at two time points: T0
at the start and T1 at the end of the active gait rehabilita-
tion programme. This period usually varies from 4 weeks
to 6 months.
The physiotherapist who was mainly responsible for the
therapy of the child completed the FMS and the FAQ at
T0 and T1, and the GRS at T1. As the therapists had no
previous experience with the FMS or FAQ, they received
brief protocolled instructions beforehand. To ensure that
the therapists filled in the forms accurately and adhered to
the standardized instructions, an independent research fel-
low (CA-R) performed a standardized interview. Both
instructions and interview were based on the directives
found on the questionnaires. To reduce risk of bias, phys-
iotherapists and the research fellow were unaware of the
other test results and did not have access to T0 ratings
when scoring FMS, FAQ, and GRS at T1. Details about
the implementation of the other tests are outlined in
Table SI (online supporting information).
Statistical analysis
Descriptive statistics are presented for relevant characteris-
tics of the study population and outcome measures. We
summarize continuously distributed data by the median
(25th–75th centiles). SPSS version 24.0 (IBM SPSS Statis-
tics, Armonk, NY, USA) was used for statistical analyses.
We treated each FMS distance as a separate measure.
For hypotheses 1 and 2, we calculated Spearman’s corre-
lation coefficients and 95% confidence intervals employing
bootstrapping, i.e. random sampling with replacement (bias
corrected and accelerated method with 1000 samples), to
quantify the relationship between the change scores of the
FMS and FAQ, the comparator measures, and the GRS.26
We were interested in changes of the construct ‘walking
capacity’ rather than in changes of each single capacity
measure. Therefore, we averaged these correlations by
transforming each of them into Fisher’s z-scores, summa-
rized and averaged these scores, and finally transferred the
averaged z-scores back into a correlation coefficient.10 We
interpreted values from 0 to 0.19 as very weak, 0.2 to 0.39
as weak, 0.4 to 0.59 as moderate, 0.6 to 0.79 as strong, and
0.8 and higher as very strong.27
To test hypothesis 3, we performed non-parametric ROC
curve analyses between the dichotomized GRS and the FMS
and FAQ.28 We considered a value of the area under the
ROC curves of at least 0.7 as appropriate to demonstrate the
ability of the FMS and FAQ to discriminate between chil-
dren who had improved and those who had not improved
according to the therapists’ ratings on the GRS.29 For
hypothesis 4, we used a Mann–Whitney U test to quantify
the differences between the two groups and set the statistical
level of significance for a two-tailed test at a=0.05.
We calculated the Youden index (sensitivity + specificity 
1) for all points of the ROC curve and selected the maximum
value of this index as the optimal cut-off point for the MIC of
the tools.29 Missing data were not replaced.
RESULTS
The active gait rehabilitation period of the 64 participants
(6–18y 6mo) lasted on average 46 days (SD 41.9d) and var-
ied between 14 days and 295 days. Further characteristics
of the study population and information on the measure-
ments are presented in Table I.
The functional abilities of the participants differed
widely and ranged over the whole spectrum of the FMS
and FAQ (Fig. 1). Thus, not all children were able to per-
form all capacity tests and/or at both time points (Table I).
Change scores varied largely from 2 to 5 for the FMS
and from 1 to 7 for the FAQ (Fig. 1).
Correlations between the change scores of the FMS and
FAQ and the change scores of the comparator tests were
all positive. The values of rs for the comparisons with
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change scores of the averaged capacity tests were 0.39,
0.49, and 0.40 for the FMS 5m, 50m, and 500m respec-
tively and 0.35 for the FAQ, while those with the Func-
tional Independence Measure for Children walking item
change scores ranged from 0.54 to 0.76 (Table IIa).
Correlations between the GRS and the change scores of
the FMS and FAQ were moderate to strong and ranged
from 0.57 to 0.76, while the GRS correlated weakly with
the change scores of the averaged capacity tests (rs=0.36;
Table IIb).
The ROC curve analyses between the dichotomized
GRS (unchanged versus somewhat better/much better) and
the FMS and FAQ change scores revealed values for the
area under the ROC curves above the a priori defined
threshold of 0.7 (FMS 5m, 50m, 500m, and FAQ: 0.79,
0.75, 0.76, and 0.80 respectively; see Fig. S1, online sup-
porting information). No child was rated as somewhat
worse/much worse on the GRS, although six children
partly deteriorated in FMS or FAQ scores.
The median change scores in the non-operated children
were 0 for the FMS and 1 for the FAQ. In the postsurgical
children, the median change scores were 3, 3, and 2 for
the FMS 5m, 50m, and 500m respectively and 3 for the
FAQ (Fig. 2). The differences were statistically significant
for all change scores between the two groups (FMS 5m,
50m, 500m, and FAQ: z=3.55, z=3.78, z=2.82, and
z=3.01 respectively; see Fig. 2).
The maximum value of the Youden index resulted in an
optimal cut-off point of 0.5 for each distance of the FMS
and 1.5 for the FAQ. Thus, in practice, children have to
improve at least one level on the FMS 5m, 50m, and 500m
and two levels on the FAQ to achieve the MIC.
DISCUSSION
We investigated the responsiveness of the FMS and FAQ
on a construct-based (correlations) and a criterion-based
(ROC curves) method with preset hypotheses in children
and adolescents with motor disorders in an inpatient neu-
rorehabilitation setting. Further, we calculated the MIC
using an anchor-based approach for the two measures.
Our results for the correlation strengths with the aver-
aged capacity change scores only partly confirmed hypoth-
esis 1, as only the FMS 50m and 500m reached the
expected level of 0.4, whereas the correlations were lower
for the FMS 5m and FAQ. These results were not in line
with previous research in outpatients, which showed strong
(positive) correlations between changes in FMS scores and
changes in outcomes of other measures of functional activ-
ity assessed with questionnaires (rs=0.75–0.83) and activity
monitors (rs=0.78–0.89).
5
The stronger correlations of the FMS and FAQ with the
change score of the Functional Independence Measure for
Children walking item in our study may reflect that these
measures all rate change in performance in everyday situa-
tions within the rehabilitation setting, while the capacity
measures required the children to perform changes on
their maximal level within a standardized test situation.
As information on the responsiveness of the clinically
often-used gait comparator measures is largely missing, we
designed a GRS to estimate therapists’ perceived change of
the children’s functional mobility in parallel. Because the
reliability of this GRS is unknown, we used it within a
construct and criterion approach.9 Correlations between
the GRS and the change scores of the FMS and FAQ were
all moderate to strong, showing that the FMS and FAQ
could adequately reflect the therapists’ judgements about
the children’s functional change in everyday life mobility
during inpatient rehabilitation. As the correlation between
the GRS and the change score of the averaged capacity
Table I: Characteristics of the study population (n=64)
Median age (IQR) (y:mo) 12:10 (4:11)
Sex (n)
Female 25
Male 39
Diagnoses (n)
Cerebral palsy 35
GMFCS level I 7
GMFCS level II 10
GMFCS level III 12
GMFCS level IV 6
TBI 8
Genetic disorders 5
Stroke 5
Encephalitis 3
Other 8
Surgery before rehabilitation (n)
No 43
Median age (IQR) (y:mo) 12:10 (5:4)
Yes 21
Median age (IQR) (y:mo) 13:5 (4:7)
Missing dataa
FMS 5m —
FMS 50m 2
FMS 500m 4
FAQ —
Score distribution of comparator tests; median (IQR)
10MWTss (m/s)
T0: 0.59 (0.67)
T1: 0.76 (0.59)
10MWTm (m/s)
T0: 0.91 (0.76)
T1: 1.1 (0.9)
6MinWT (m)
T0: 221 (271)
T1: 307 (259)
GMFM E (%)
T0: 47 (65)
T1: 56 (75)
WeeFIM walking
T0: 5 (4)
T1: 6 (1)
Time range of measurements (d)
T0: median (IQR) 3 (4)
T1: median (IQR) 2 (3)
aMissing data can be attributed to children who did not cover these
distances in any form at the time of data collection. IQR, interquar-
tile range; GMFCS, Gross Motor Function Classification System;
TBI, traumatic brain injury; FMS, Functional Mobility Scale; FAQ,
Gillette Functional Assessment Questionnaire walking scale;
10MWTss/m, 10-Metre Walking Test self-selected/maximal speed;
T0, start of active gait rehabilitation; T1, end of active gait rehabilita-
tion; 6MinWT, 6-Minute Walking Test; GMFM E, Gross Motor Func-
tion Measure Dimension E; WeeFIM walking, Functional
Independence Measure for Children walking item.
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tests was only weak, hypothesis 2 was confirmed. We could
also confirm hypothesis 3, in which we used the GRS as
the external criterion of the children’s change in functional
mobility. The values of the area under the ROC curves
ranged between 0.75 and 0.80 and showed that both FMS
and FAQ could be used to discriminate between children
whose walking performance remained unchanged and those
who improved.
We additionally compared the mean changes of the FMS
and FAQ in subgroups of children who had undergone
orthopaedic surgery and the other children, because the
first group was expected to improve more than the other
one. The first rating took place when children just started
active gait rehabilitation and were allowed to start loading
their legs after orthopaedic surgery. Because of this low ini-
tial level of walking ability, we expected the postsurgical
children to improve more distinctly than the others.
Despite the fact that the non-surgical group also comprised
children with acute acquired injuries whom we expected to
undergo large improvements due to spontaneous neurologi-
cal recovery in combination with the rehabilitation
programme, we could confirm hypothesis 4. Also, a previ-
ous study on the FMS in the outpatient setting demon-
strated longitudinal changes in the outcomes of the scale in
children who had received orthopaedic multilevel surgery.5
It is important to notice that the potential of improve-
ment largely depends on a child’s basic motor abilities.
Using Rasch analysis, Stout et al. provided a common scale
for different classification systems and outcome measures
of physical functioning. With that, they illustrated the
probability of successfully performing tasks of different dif-
ficulty levels depending on an individual’s present motor
abilities.30 Consequently, a child with a score of 1 for the
FMS 5m, 50m, and 500m at T0 will have more space for
improvement than a child entering rehabilitation with a
score of 6. In our study, 38% of the children had a score
of 1 over all three distances of the FMS (which decreased
to 20% at the second measurement time point). Although
this could be interpreted as a floor effect, it is not of inter-
est so long as the measure is used to evaluate functional
mobility for a child’s walking ability.9 A ceiling effect was
not an issue, as only 8% of the children had an initial
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Figure 1: Frequency distributions of the Functional Mobility Scale (FMS) 5m, 50m, and 500m and the Gillette Functional Assessment Questionnaire walk-
ing scale (FAQ). T0, start of active gait rehabilitation; T1, end of active gait rehabilitation.
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score of 6 (compared with 17% at the end). For possible
floor and ceiling effects of the FAQ, only 3% and 0% of
the children had initially the lowest and highest possible
scores respectively.
So far, responsiveness has only been evaluated for the
FMS.5,14 The correlations in our study were lower than
previously reported. A reason may be that the other studies
took place in the outpatient setting, exclusively looked at
children after surgery, and used other comparator instru-
ments. However, we were not able to test this assumption
because in our study the sample sizes of specific subgroups
were too small to calculate reliable correlations.
The MIC values indicate a 1-point (FMS) and 2-point
(FAQ) increase to be clinically meaningful. These values
Table II: Spearman’s correlations (95% confidence intervals) between (a) the change scores of the Functional Mobility Scale (FMS), the Gillette Func-
tional Assessment Questionnaire walking scale (FAQ), and other gait measures and (b) the global rating scale (GRS) of the therapists’ perceived change
and the change scores of gait measures
(a) Correlations between change scores of the FMS and FAQ and those of the comparator tests
DCapacity tests D10MWTss D10MWTm D6MinWT DGMFM E DWeeFIM walking
DFMS 5m 0.39 (0.06 to 0.72) 0.20 (0.45 to 0.72) 0.47 (0.14 to 0.73) 0.50 (0.18 to 0.75) 0.37 (0.08 to 0.68) 0.54 (0.28 to 0.74)
n 23 19 20 23 53
DFMS 50m 0.49 (0.06 to 0.77) 0.38 (0.02 to 0.68) 0.70 (0.43 to 0.85) 0.36 (0.14 to 0.71) 0.45 (0.16 to 0.79) 0.73 (0.58 to 0.85)
n 23 19 20 23 52
DFMS 500m 0.40 (0.15 to 0.77) 0.40 (0.08 to 0.73) 0.35 (0.37 to 0.77) 0.41 (0.00 to 0.75) 0.45 (0.13 to 0.80) 0.61 (0.39 to 0.79)
n 22 19 20 23 50
DFAQ 0.35 (0.10 to 0.70) 0.19 (0.34 to 0.64) 0.42 (0.09 to 0.75) 0.44 (0.08 to 0.72) 0.36 (0.06 to 0.68) 0.76 (0.62 to 0.84)
n 23 19 20 23 53
(b) Correlations between the GRS and change scores of the gait measures
Performance measures DFMS 5m DFMS 50m DFMS 500m DFAQ DWeeFIM Walking
0.57 (0.36 to 0.73) 0.67 (0.48 to 0.83) 0.64 (0.47 to 0.76) 0.67 (0.51 to 0.79) 0.63 (0.43 to 0.79)
n 63 59 59 63 52
Capacity measures DCapacity tests D10MWTss D10MWTm D6MinWT DGMFM E
0.36 (0.13 to 0.71) 0.45 (0.02 to 0.73) 0.09 (0.48 to 0.61) 0.45 (0.04 to 0.74) 0.43 (0.06 to 0.74)
n 23 19 20 23
D, change score; 10MWTss/m, 10-Metre Walking Test self-selected/maximal speed; 6MinWT, 6-Minute Walking Test; GMFM E, Gross Motor
Function Measure Dimension E; WeeFIM walking, Functional Independence Measure for Children walking item.
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Figure 2: Comparison of change scores between children who had received surgery or not before undergoing rehabilitation. FMS, Functional Mobility
Scale; FAQ, Gillette Functional Assessment Questionnaire walking scale; horizontal line, median; box, interquartile range; whiskers, 1.59 interquartile
range; small circle, mild outlier (more than 1.59 interquartile range); star, extreme outlier (more than 39 interquartile range).
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seem logical from a contextual point, as each level of the
FMS signifies the (in)dependence on/from another type of
walking device, while the FAQ levels vary unevenly in
terms of distance, environment, mobility, and indepen-
dence. However, as both measures are ordinal-scaled, the
MIC may be different for children on the lower and higher
ends of the scales. Our reported MIC of 2 for the FAQ is
consistent with the overlapping item difficulty levels for
the FAQ levels 5 and below and level 6 derived by Rasch
analysis.30 Considering the results of the Rasch analysis, an
MIC of 1 might be more likely for children classified in
FAQ level 7 and higher at T0. To address these potential
differences over the whole range of the scales, thus
enabling an estimation of the MIC for individual patients,
larger samples of patients would be necessary to allow a
differentiation between various motor ability subgroups.
Methodological considerations
The FMS distances represent children’s usual surroundings
(home, school, and community), which we had to substitute
for the inpatient setting. However, previous research on the
interrater reliability between health professionals, who mea-
sured inpatient everyday life mobility, and parents, who
rated their child’s mobility in the usual environments, pro-
vides evidence that our adaptations made for the inpatient
setting seem to correspond well to the home setting.12 In
line with the recommendations of de Vet et al.,9 we used an
anchor-based approach to assess the MIC, as this includes a
definition of what is considered minimally important. Of
course, the rating of the parents or even children could be
considered most relevant in the context of MIC. However,
because of the inpatient setting (parents are not present
throughout the day; for most children it would be difficult
to remember the initial situation), the GRS was rated by the
therapists. For the same reasons, the therapists scored the
FMS and FAQ, in contrast to the measures’ original test
administration, which involved child-report or parent-
report. The fact that the GRS was rated by the treating ther-
apist could have resulted in a slight overestimation of the
perceived change. Although we had to dichotomize the GRS
ratings for the ROC analysis at an arbitrarily chosen cut-off
point, analyses showed that the MICs would not change with
another selected cut-off level. Unfortunately, we could not
compare the MIC with the smallest detectable change, as
the latter is still unknown for both measures.
Although we exceeded the targeted sample size of 50,
the samples were smaller for the analyses with the capacity
tests and the subgroups for surgical/non-surgical interven-
tion. Because we aimed for a representative sample of our
inpatient rehabilitation setting, this meant that not every
included patient was able to perform every test at both
time points. This fact could have biased the reported cor-
relations for hypotheses 1 and 2. However, as the groups
with and without capacity test data did not differ systemat-
ically, the correlations can be applied to the entire patient
sample. The duration between the two rating time points
varied considerably, which is an inevitable characteristic in
neurorehabilitation. At the same time, the heterogeneity of
our sample in terms of age, diagnoses, mobility levels, and
rehabilitation duration facilitates the transfer of our results
to other inpatient settings.
CONCLUSION
We evaluated the responsiveness of the FMS and FAQ
within a paediatric inpatient setting. We have shown that
both tools are suitable for depicting the change that has
occurred in children’s gait performance. Moreover, the
results facilitate the interpretation of FMS and FAQ scores
in clinical practice and research by defining an MIC for
both tools.
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RESUMEN
MEDICION DEL CAMBIO EN EL DESEMPE~NO DE LA MARCHA EN NI~NOS CON TRASTORNOS MOTORES: EVALUACION DE LA ESCALA
DE MOVILIDAD FUNCIONAL Y EL CUESTIONARIO DE EVALUACION FUNCIONAL DE GILLETTE
OBJETIVO Examinar la sensibilidad y el cambio mınimo significativo de dos mediciones de desempe~no de la marcha, la Escala de
Movilidad Funcional (FMS) y el Cuestionario de Evaluacion Funcional de Gillette (FAQ), en una poblacion de pacientes pediatricos
hospitalizados.
METODO Se reclutaron sesenta y cuatro ni~nos y adolescentes con algun trastorno motor, incluyendo paralisis cerebral, lesion
cerebral traumatica o accidente cerebrovascular (25 mujeres, 39 varones; edad promedio [DE] 12a 6m [3a 2m], rango 6a – 18a 6m).
Fisioterapeutas aplicaron las escalas FMS y FAQ al principio y final del proceso de rehabilitacion activa de la marcha. Los puntajes
de cambio fueron comparados con los cambios en pruebas de capacidad de marcha, el ıtem de marcha de la escala WeeFIM
(Functional Independence Measure for Children) y una escala global de calificacion (EGC) sobre la percepcion del fisioterapeuta
del cambio en la movilidad funcional del ni~no. La EGC se utilizo, ademas, para definir el cambio mınimo significativo.
RESULTADOS Los puntajes de cambio de la FMS y el FAQ tuvieron una correlacion de 0,35 a 0,49 con lo de la prueba de
capacidad de marcha, 0,54 a 0,76 con el ıtem de marcha de la escala WeeFIM, y 0,57 a 0,76 con la EGC. El cambio mınimo
significativo para la FMS y el FAQ fueron 0,5 y 1,5, respectivamente.
INTERPRETACION La FMS y el FAQ permiten observar cambios en el desempe~no de la marcha de pacientes pediatricos y
adolescentes hospitalizados con trastornos motores. Un cambio positivo de un nivel en la FMS y de dos niveles en el FAQ se
considera un cambio clınicamente significativo.
RESUMO
MENSURANDO MUDANCA NO DESEMPENHO DA MARCHA EM CRIANCAS COM DESORDENS MOTORAS: AVALIANDO A ESCALA DE
MOBILIDADE FUNCIONAL A ESCALA DA MARCHA DO QUESTIONARIO DE AVALIAC~AO FUNCIONAL GILLETTE
OBJETIVO Examinar a responsividade e mınima mudanca importante (MMI) de tduas medidas do desempenho da marcha, a
Escala de mobilidade funcional (FMS), e a escala da marcha do Questionario de Avaliac~ao Funcional Gillette (FAQ), em uma
unidade de internac~ao pediatrica.
METODO Sessenta e quatro criancas e adolescentes com uma desordem motora, incluindo paralisia cerebral, les~ao cerebral
traumatica, ou acidente vascular encefalico (25 do sexo feminino, 39 do sexo masculino; media de idade [DP] 12a 6m [3a 2m],
variac~ao 6a–18a 6m), foram recrutadas. Fisioterapeutas pontuaram a FMS e FAQ no inıcio e final da reabilitac~ao ativa da marcha.
Mudancas nos escores foram comparadas com mudancas nos testes de capacidade da marcha, no item de marcha da Medida de
Independe^ncia Funcional para criancas, e uma Escala Global de Pontuac~ao (EGP) sobre as mudancas percebidas pelos
fisioterapeutas na mobilidade funcional da crianca. A EGP tambem foi usada para determinar a MMI.
RESULTADOS Os escores de mudanca da FMS e FAQ correlacionaram entre 0,35 e 0,49 com os dos testes de capacidade, 0,54 a
0,76 com a mudaca de escores no item de marcha da medida de Independe^ncia Funcional para criancas, e 0,57 a 0,76 com a EGP.
A MMI para FMS e FAQ foi 0,5 e 1,5, respectivamente.
INTERPRETAC~AO FMS e FAQ podem ilustrar mudancas no desempenho da marcha em criancas e adolescentes com desordens
motoras que se encontram internados. Uma melhora de um nıvel na FMS e dois nıveis na FAQ e considerada mudanca
clinicamente significativa.
